Chen R, Yu Y, Liu R, Chen Q
Transl Cancer Res. 2024; 13(11):6550-6564.
PMID: 39697732
PMC: 11651813.
DOI: 10.21037/tcr-24-1129.
Marverti G, Moschella M, Belardo A, Lamesta M, Mercanile G, Tagliazucchi L
Front Pharmacol. 2024; 15:1477318.
PMID: 39611169
PMC: 11602703.
DOI: 10.3389/fphar.2024.1477318.
Vig S, Srivastava P, Rahman I, Jaranson R, Dasgupta A, Perttila R
Cancer Drug Resist. 2024; 7:35.
PMID: 39403604
PMC: 11472579.
DOI: 10.20517/cdr.2024.50.
Usui K, Yamamoto H, Mori H, Fujita Y
Plant Cell Physiol. 2024; 66(2):214-228.
PMID: 39172638
PMC: 11879085.
DOI: 10.1093/pcp/pcae095.
Vahdati S, Lamprecht A
Pharmaceutics. 2024; 16(4).
PMID: 38675154
PMC: 11053612.
DOI: 10.3390/pharmaceutics16040493.
Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood-brain barrier.
Thomas J, Frye W, Robey R, Warner A, Butcher D, Matta J
Fluids Barriers CNS. 2024; 21(1):27.
PMID: 38491505
PMC: 10941402.
DOI: 10.1186/s12987-024-00529-5.
Effectiveness of lapatinib for enhancing 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy in human cancer cell lines with varied ABCG2 activities.
Howley R, Olsen J, Chen B
Photochem Photobiol. 2024; 100(6):1579-1589.
PMID: 38477138
PMC: 11393173.
DOI: 10.1111/php.13936.
Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.
Quinlan J, Inglut C, Srivastava P, Rahman I, Stabile J, Gaitan B
Adv Sci (Weinh). 2024; 11(17):e2302872.
PMID: 38445882
PMC: 11077681.
DOI: 10.1002/advs.202302872.
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?.
Damiani D, Tiribelli M
Biomedicines. 2024; 12(1).
PMID: 38255216
PMC: 10813371.
DOI: 10.3390/biomedicines12010111.
Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.
Li Y, Hsiao S, Murakami M, Huang Y, Chang Y, Hung T
ACS Pharmacol Transl Sci. 2024; 7(1):161-175.
PMID: 38230272
PMC: 10789147.
DOI: 10.1021/acsptsci.3c00217.
Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport.
Wu C, Murakami M, Li Y, Huang Y, Chang Y, Hung T
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004460
PMC: 10674403.
DOI: 10.3390/ph16111595.
Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S, Olsen J, Howley R, Chen B
Biochem Pharmacol. 2023; 217:115851.
PMID: 37858868
PMC: 10842008.
DOI: 10.1016/j.bcp.2023.115851.
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers.
Frye W, Huff L, Gonzalez Dalmasy J, Salazar P, Carter R, Gensler R
Cancer Drug Resist. 2023; 6(6):468-480.
PMID: 37840856
PMC: 10571053.
DOI: 10.20517/cdr.2023.29.
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.
Wu C, Li Y, Murakami M, Hsiao S, Lee Y, Huang Y
Int J Mol Sci. 2023; 24(18).
PMID: 37762275
PMC: 10531071.
DOI: 10.3390/ijms241813972.
Excitation of a Single Compound by Light and Ultrasound Enhanced the Long-Term Cure of Mice Bearing Prostate Tumors.
Cacaccio J, Durrani F, Kumar I, Dukh M, Camacho S, Fayazi Z
Int J Mol Sci. 2023; 24(13).
PMID: 37445799
PMC: 10341536.
DOI: 10.3390/ijms241310624.
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors.
van der Noord V, van der Stel W, Louwerens G, Verhoeven D, Kuiken H, Lieftink C
Breast Cancer Res. 2023; 25(1):51.
PMID: 37147730
PMC: 10161439.
DOI: 10.1186/s13058-023-01648-x.
ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines.
Wu C, Hung C, Hsieh Y, Murakami M, Huang Y, Su T
Cells. 2023; 12(7).
PMID: 37048130
PMC: 10093605.
DOI: 10.3390/cells12071056.
Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells.
Li Y, Murakami M, Huang Y, Hung T, Wang S, Wu Y
Int J Mol Sci. 2022; 23(21).
PMID: 36361555
PMC: 9658017.
DOI: 10.3390/ijms232112763.
The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.
Teodori E, Braconi L, Manetti D, Romanelli M, Dei S
Curr Top Med Chem. 2022; 22(31):2535-2569.
PMID: 36284399
DOI: 10.2174/1568026623666221025111528.
Biological Assay-Guided Fractionation and Mass Spectrometry-Based Metabolite Profiling of L. Cytotoxic Compounds against Lung Cancer A549 Cell Line.
Salac E, Alvarez M, Gaurana R, Grijaldo S, Serrano L, De Juan F
Plants (Basel). 2022; 11(18).
PMID: 36145779
PMC: 9503541.
DOI: 10.3390/plants11182380.